PetMed Express
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PetMed Express generated cash of $4,317,000, which is less than the previous year. Cash used in financing activities reached the amount of -$12,437,000 last year. Net change in cash is therefore -$48,790,000.
Cash Flow
| 2015 | 32.04M | -986K | -13.74M |
|---|---|---|---|
| 2016 | 21.05M | -4.48M | -14.54M |
| 2017 | 47.20M | -10.60M | -15.50M |
| 2018 | 37.37M | -703K | -17.47M |
| 2019 | 45.13M | -620K | -21.92M |
| 2020 | 38.84M | -2.31M | -33.3M |
| 2021 | 40.07M | -2.43M | -22.68M |
| 2022 | 18.49M | -1.75M | -24.38M |
| 2023 | 27.80M | -10.26M | -24.53M |
| 2024 | 4.31M | -40.67M | -12.43M |
PETS Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 104.08M | 111.08M | 118.71M | 103.76M | 100.52M | 77.93M | 58.73M | 37.63M | 35.61M | 18.30M |
Operating activities | ||||||||||
Net income | -7.46M | 233K | 21.1M | 30.60M | 25.85M | 37.74M | 37.28M | 23.81M | 20.56M | 17.45M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 7.05M | 3.54M | 2.73M | 2.42M | 2.25M | 2.22M | 2.12M | 1.36M | 770K | 660K |
Stock-based compensation expense | 6.86M | 6.61M | 4.54M | 3.30M | 2.82M | 3.09M | 2.57M | 1.93M | 1.61M | 1.48M |
| Deferred income tax benefit | 6.86M | 6.61M | 4.54M | 3.30M | 2.82M | 3.09M | 2.57M | 1.93M | 1.61M | 1.48M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.74M | -41K | 509K | 1.12M | -1.49M | -335K | -596K | -505K | -53K | -264K |
Inventories | -6.41M | 13.43M | 1.96M | -16.53M | 3.48M | 1.96M | -3.10M | 5.35M | -518K | 10.65M |
Accounts payable | 6.10M | -2.29M | -12.04M | 19.89M | 3.38M | 1.00M | 53K | 10.21M | -149K | -616K |
Cash generated by operating activities | 4.31M | 27.80M | 18.49M | 40.07M | 38.84M | 45.13M | 37.37M | 47.20M | 21.05M | 32.04M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -68K |
Investments In Property Plant And Equipment | -4.51M | -5.26M | -1.75M | -2.43M | -2.31M | -620K | -703K | -10.60M | -20.13M | -918K |
Acquisitions Net | -36.15M | -5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -40.67M | -10.26M | -1.75M | -2.43M | -2.31M | -620K | -703K | -10.60M | -4.48M | -986K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -12.43M | -24.53M | -24.38M | -22.68M | -21.80M | -21.92M | -17.47M | -15.50M | -14.68M | -13.80M |
Repurchases of common stock | 0 | 0 | 0 | 0 | -11.49M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -12.43M | -24.53M | -24.38M | -22.68M | -33.3M | -21.92M | -17.47M | -15.50M | -14.54M | -13.74M |
Net Change In Cash | -48.79M | -6.99M | -7.63M | 14.95M | 3.23M | 22.59M | 19.20M | 21.09M | 2.02M | 17.30M |
Cash at end of period | 55.29M | 104.08M | 111.08M | 118.71M | 103.76M | 100.52M | 77.93M | 58.73M | 37.63M | 35.61M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |